vTv Therapeutics VTVT
NASDAQ VTVT
$30.66 -1.19 (-3.74%)
As of: Oct 2, 2026 · 3:14 PM EDT

vTv Therapeutics (VTVT) Accumulated Depreciation (2014 - 2021)

Updated

vTv Therapeutics' Accumulated Depreciation was $305,000 in Q4 2021, up 41.2% from $216,000 a year earlier.

Analysis

vTv Therapeutics (VTVT) Accumulated Depreciation (2014 - 2021) Analysis & Trends

From Q4 2014 onward, vTv Therapeutics has reported Accumulated Depreciation for 8 quarters.

  • Accumulated Depreciation shows a five-year compound annual growth rate of -50.7% (FY2016 to FY2021).
  • In earlier years, Accumulated Depreciation was $216,000 in FY2020 (+45.9%), $148,000 in FY2019 (-98.2%), $8.43 million in FY2018 (-7.5%) and $9.12 million in FY2017 (-12.8%).
  • The Q4 2021 figure marks the highest quarterly Accumulated Depreciation since Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 vTv Therapeutics 382.70 Mn 382.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 305,000.00
Dec 31, 2020 216,000.00
Dec 31, 2019 148,000.00
Dec 31, 2018 8.43 Mn
Dec 31, 2017 9.12 Mn
Dec 31, 2016 10.45 Mn
Dec 31, 2015 11.09 Mn
Dec 31, 2014 11.84 Mn
API Access

vTv Therapeutics Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=VTVT&period=max&api_key=YOUR_API_KEY